EUVIMEDEUVIMED entdecken
Crossref

A label-free cell-based screening identifies enhydrin as a novel natural antagonist of the histamine H1 receptor

Ziwei Zhang, Qichao Hu, Hanzhen Wang, Zhichao Zhou, Zhan Si, Liying Shi

Molecular Diversity · 2026

DOI: 10.1007/s11030-026-11549-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2026. Verfasst von Ziwei Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Health, Dalian University, Dalian, 116622, China. Hauptthemen laut MEDLINE: Receptors, Histamine H1, Sesquiterpenes, Histamine H1 Antagonists, Lactones. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histamine H1 receptor antagonists are widely used to treat allergic conditions. As some synthetic drugs in this class are associated with adverse effects, discovering new antagonists from natural sources remains an active pursuit. Efficient screening methods that evaluate receptor function in a physiologically relevant, integrated manner are still needed. In this study, we developed a label-free, cell-based assay to screen for H1 receptor antagonists by monitoring dynamic mass redistribution (DMR) in A431 cells, which endogenously express H1 receptor. After validating the system with reference agonists and antagonists, we screened a panel of 32 natural compounds and identified four initial hits, including the sesquiterpene lactone enhydrin. Enhydrin dose-dependently antagonize‌d histamine-induced DMR responses and downstream p38 MAPK (mitogen-activated protein kinase) phosphorylation, and it prevented agonist-triggered internalization of the H1 receptor. Molecular docking and dynamics simulations supported a direct mechanism, showing that enhydrin forms a stable complex within the receptor binding pocket through sustained interactions with residues including LYS191, ASN198, and TRP428. Our findings establish enhydrin as a promising therapeutic candidate for allergic inflammatory responses by antagonizing the H1 receptor. This study extends the label-free cell-based screening of H1 receptor antagonists, thereby facilitating the discovery of novel anti-allergic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Histamine H1SesquiterpenesHistamine H1 AntagonistsLactonesBiological ProductsHumansMolecular Docking SimulationMolecular Dynamics SimulationPhosphorylationp38 Mitogen-Activated Protein KinasesCell Line, TumorDrug Evaluation, Preclinical

Stichwörter der Autor:innen

Antagonist discoveryEnhydrinHistamine H1 receptorLabel-free screeningMolecular dynamics

Substanzen

Receptors, Histamine H1SesquiterpenesHistamine H1 Antagonistsp38 Mitogen-Activated Protein KinasesLactonesBiological Products

Autor:innen und Institutionen

  • School of Life and Health, Dalian University, Dalian, 116622, China.
  • School of Life and Health, Dalian University, Dalian, 116622, China. shiliying@dlu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Z., Hu, Q., Wang, H., Zhou, Z., Si, Z., & Shi, L. (2026). A label-free cell-based screening identifies enhydrin as a novel natural antagonist of the histamine H1 receptor. Molecular Diversity. https://doi.org/10.1007/s11030-026-11549-8

Vancouver

Zhang Z, Hu Q, Wang H, Zhou Z, Si Z, Shi L. A label-free cell-based screening identifies enhydrin as a novel natural antagonist of the histamine H1 receptor. Molecular Diversity. 2026. doi:10.1007/s11030-026-11549-8

BibTeX
@article{Zhang2026,
  author = {Zhang, Ziwei and Hu, Qichao and Wang, Hanzhen and Zhou, Zhichao and Si, Zhan and Shi, Liying},
  title = {A label-free cell-based screening identifies enhydrin as a novel natural antagonist of the histamine H1 receptor},
  journal = {Molecular Diversity},
  year = {2026},
  doi = {10.1007/s11030-026-11549-8}
}
Kostenlos starten →